Abveris Inc. Sustainability Profile
Abveris Inc., a leading biotechnology company headquartered in the United States, specialises in the development of innovative antibody discovery solutions. Founded in 2012, Abveris has established itself as a key player in the biopharmaceutical industry, particularly in the areas of therapeutic antibody development and protein engineering. With a focus on utilising advanced technologies, Abveris offers unique services that streamline the antibody discovery process, ensuring high specificity and affinity. The company has achieved significant milestones, including collaborations with major pharmaceutical firms, which underscore its strong market position. Abveris continues to drive advancements in antibody therapeutics, making it a trusted partner for organisations seeking cutting-edge solutions in drug development.
DitchCarbon Score
How does Abveris Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abveris Inc.'s score of 15 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abveris Inc.'s reported carbon emissions
Abveris Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Twist Bioscience Corporation, which may influence its climate commitments and reporting practices. While Abveris has not established its own reduction targets or climate pledges, it is important to note that it inherits certain sustainability initiatives from its parent company, Twist Bioscience Corporation. This includes participation in the Carbon Disclosure Project (CDP) and the Science Based Targets initiative (SBTi) at a cascading level, which may guide its future climate strategies. As the industry increasingly prioritises sustainability, Abveris Inc. is positioned to align with broader corporate climate commitments through its relationship with Twist Bioscience, potentially adopting similar reduction targets and initiatives in the future.
How Carbon Intensive is Abveris Inc.'s Industry?
How Carbon Intensive is Abveris Inc.'s Location?
Abveris Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abveris Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
